Litigation Risk
First written in FY2017. 5 of 6 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2018: 1 of 6 companies on the "Worse" side.
5 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「In conducting business activities continuously in Japan and overseas, we may face litigation relating to matters including pharmaceutical side effects, product liability, labor, the environment and fair trade.」
Litigation risks relating to side effects, product liability, labor, the environment and fair trade, among other matters, continue to be disclosed. - FY2022RestatedAnnual report
「In conducting business activities continuously in Japan and overseas, we may face litigation relating to matters including pharmaceutical side effects, product liability, labor, the environment and fair trade.」
Litigation risks relating to pharmaceutical side effects, product liability, labor, the environment and fair trade, among other matters, continue to be disclosed. - FY2021RestatedAnnual report
「In conducting business activities continuously in Japan and overseas, we may face litigation relating to matters including pharmaceutical side effects, product liability, labor, the environment and fair trade.」
The disclosure of litigation risks continues, listing specific areas including pharmaceutical side effects, product liability, labor, the environment and fair trade. - FY2019RestatedAnnual report
「In the course of conducting business, we may face litigation, which could affect business performance.」
The disclosure of litigation risks arising from business activities continues. - FY2018RestatedAnnual report
「In the course of conducting business, we may face litigation, which could affect business performance.」
The risk of litigation arising from business activities continues to be disclosed. - FY2017First statedAnnual report
「In the course of conducting business, we may face litigation, which could affect business performance.」
The possibility of litigation arising from business activities and affecting business performance is disclosed as a risk.